(Q34962911)

5 August 2017

1 reference

title

CD8+ T cells in tuberculosis (English)

1 reference

5 August 2017

0 references

Vanja Lazarevic

1

1 reference

PubMed ID

12379557

5 August 2017

JoAnne Flynn

series ordinal

2

1 reference

PubMed ID

12379557

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

5 August 2017

1 reference

5 August 2017

166

1 reference

5 August 2017

1116-1121

1 reference

5 August 2017

8

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

5 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Differential effects of cytolytic T cell subsets on intracellular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

An antimicrobial activity of cytolytic T cells mediated by granulysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

Cytolytic T cells in the immune response to mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2204027

21 January 2018

Identifiers

DOI

10.1164/RCCM.2204027

1 reference

5 August 2017

1 reference

PubMed ID

12379557